Status:
COMPLETED
Observational Study of Ultravist in Patients Requiring CECT
Lead Sponsor:
Bayer
Conditions:
Diagnostic Imaging
Eligibility:
All Genders
Brief Summary
It is a prospective, non-interventional, multi-center study. The primary objective of this study is to evaluate the image quality of Ultravist in patients requiring contrast-enhanced CT considering th...
Eligibility Criteria
Inclusion
- Patients undergoing contrast enhanced CT Imaging with Ultravist (iopromide) in abdomen or pelvis.
Exclusion
- There is no other exclusion criteria beyond the contraindications contained in the Summary of Product Characteristics
Key Trial Info
Start Date :
September 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2013
Estimated Enrollment :
11660 Patients enrolled
Trial Details
Trial ID
NCT01415414
Start Date
September 1 2011
End Date
November 1 2013
Last Update
January 21 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Many Locations, China